By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Nexus AG

Nexus AG (0FGL.L)

LSE Currency in EUR
€70.70
+€0.20
+0.28%
Last Update: 15 Jul 2025, 15:29
€1.22B
Market Cap
37.41
P/E Ratio (TTM)
0.33%
Forward Dividend Yield
€44.30 - €70.70
52 Week Range

0FGL.L Stock Price Chart

Explore Nexus AG interactive price chart. Choose custom timeframes to analyze 0FGL.L price movements and trends.

There is nothing to show.

0FGL.L Company Profile

Discover essential business fundamentals and corporate details for Nexus AG (0FGL.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Equipment & Services

IPO Date

18 Jun 2010

Employees

1.91K

CEO

Ingo Behrendt MBA

Description

Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.

0FGL.L Financial Timeline

Browse a chronological timeline of Nexus AG corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 18 May 2026

Upcoming earnings on 2 Mar 2026

Upcoming earnings on 4 Nov 2025

Upcoming earnings on 12 Aug 2025

Dividend declared on 23 May 2025

A dividend of €0.23 per share was announced, adjusted to €0.23. The dividend was paid on 27 May 2025.

Earnings released on 20 May 2025

Earnings released on 3 Mar 2025

EPS came in at €0.61 surpassing the estimated €0.49 by +24.29%, while revenue for the quarter reached €70.66M, missing expectations by -6.04%.

Earnings released on 5 Nov 2024

EPS came in at €0.46 surpassing the estimated €0.36 by +27.19%, while revenue for the quarter reached €63.14M, missing expectations by -16.04%.

Earnings released on 13 Aug 2024

EPS came in at €0.34 surpassing the estimated €0.33 by +2.30%, while revenue for the quarter reached €65.77M, beating expectations by +1.18%.

Dividend declared on 16 May 2024

A dividend of €0.22 per share was announced, adjusted to €0.22. The dividend was paid on 20 May 2024.

Earnings released on 14 May 2024

EPS came in at €0.38, while revenue for the quarter reached €62.99M, missing expectations by -0.02%.

Earnings released on 5 Mar 2024

EPS came in at €0.37, while revenue for the quarter reached €70.19M.

Earnings released on 30 Sept 2023

EPS came in at €0.39, while revenue for the quarter reached €59.42M, beating expectations by +3.35%.

Earnings released on 30 Jun 2023

EPS came in at €0.30, while revenue for the quarter reached €56.82M.

Dividend declared on 17 May 2023

A dividend of €0.21 per share was announced, adjusted to €0.21. The dividend was paid on 22 May 2023.

Earnings released on 31 Mar 2023

EPS came in at €0.33, while revenue for the quarter reached €55.02M, beating expectations by +3.81%.

Earnings released on 31 Dec 2022

EPS came in at €0.34, while revenue for the quarter reached €58.34M, missing expectations by -7.25%.

Earnings released on 30 Sept 2022

EPS came in at €0.28, while revenue for the quarter reached €50.76M, missing expectations by -8.05%.

Earnings released on 30 Jun 2022

EPS came in at €0.31, while revenue for the quarter reached €50.53M.

Earnings released on 31 Mar 2022

EPS came in at €0.26, while revenue for the quarter reached €49.50M, missing expectations by -1.20%.

Earnings released on 31 Dec 2021

EPS came in at €0.40, while revenue for the quarter reached €50.96M.

Earnings released on 30 Sept 2021

EPS came in at €0.22, while revenue for the quarter reached €46.37M.

Earnings released on 30 Jun 2021

EPS came in at €0.24, while revenue for the quarter reached €46.92M.

Earnings released on 31 Mar 2021

EPS came in at €0.23, while revenue for the quarter reached €43.94M.

Earnings released on 31 Dec 2020

EPS came in at €0.39, while revenue for the quarter reached €48.28M.

Earnings released on 30 Sept 2020

EPS came in at €0.17, while revenue for the quarter reached €38.62M.

0FGL.L Stock Performance

Access detailed 0FGL.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
0FGL.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
0FGL.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More